Skip to main content
Figure 2 | BMC Ophthalmology

Figure 2

From: Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain

Figure 2

Evolution to atrophy. This patient followed for 3 years and 7 months needed only the 3 first injections of the loading phase and none thereafter; a) initial fundus picture showed lipidic exudates at the superior border of the lesion; c) initial OCT showed intraretinal and subretinal fluid and logMAR VA was 0.8 (20/125). A year later she a year later she began developing atrophy which increased over the years; b) fundus final picture; d) final OCT status; e) final autofluorescence with atrophy not affecting the fovea which explains a final logMAR VA 0,2 (20/32).

Back to article page